Our Story

Aurobindo Through the Years

Creation of a Leading Vertically Integrated Platform

2020

icon-injectables
Auro Vaccines – Acquired Profectus which will help us launch our Vaccine division.

2019

icon-packaging

Auro Packaging – Packaging Division.

2018

icon-agreement

Acrotech Biopharma – Brand Division. Acquired seven marketed oncology products from Spectrum Pharmaceuticals.

2017

icon-distribution

Opened 567,000 sq. ft. fully automated state-of-art distribution center in East Windsor, NJ

Opened a new, 40,000 sq. ft. specialty pharma R&D facility in Durham, NC

APL acquired 4 cell culture-derived biosimilar products from Swiss TL Biopharmaceutical. Three out of the four biosimilars are monoclonal antibodies in oncology.

APL acquires Portugal’s Generis Farmaceutica SA

2016

icon-packaging

Aurobindo Pharma USA, Inc. moves Corporate Headquarters to East Windsor, NJ, USA

2015

icon-invest

Investment into Tergene to fund the development of a pneumonia vaccine

2014

icon-agreement

Aurobindo Pharma USA, Inc. acquires Natrol Inc. in California, USA

Aurohealth LLC begins doing business in Lawrenceville, NJ, USA

Focus on differentiated technology platforms eg. depot injections

APL acquires commercial operations in Western Europe from Actavis making it one of the leading Indian pharmaceutical companies in Europe.

2013

icon-injectables

Commenced marketing specialty injectables to fund the development in USA through AuroMedics

Building capabilities in Penem, Oncology & Biocatalysis

2012

icon-check

First approval of Controlled Substance formulations in USA

Set up AuroPeptide to foray into peptide business

Aurohealth LLC, our OTC division becomes an entity

2011

icon-injectables

AuroMedics Pharma LLC begins selling and distributing Injectables in the USA

2010

icon-gears

Commenced operations of SEZ Unit VII and Aurolife, USA facilities and divested Chinese antibiotics products facility

2008

icon-bottle

Aurolife Pharma LLC begins manufacturing solid oral dose.

2007

icon-flask

Acquired formulations facility in USA

Investment in building manufacturing, marketing & IPR capabilities

2006

icon-warehouse

Acquired building from Sandoz to begin Aurolife Manufacturing in Dayton, NJ, USA

2004

icon-globe

Aurobindo Pharma USA, Inc. becomes incorporated in USA

1992-2002

icon-ingredients

Commencement of export of APIs

Initial Public Offering (1995)

Began production of formulations